TRAIL, Fas Ligand, TNF and TLR3 in Cancer
This volume provides the current understanding of death receptor's/TLR3 signaling regulation in cancer. Death receptors, including TRAIL-R1, TRAIL-R2, Fas and TNF-RI, owing to their ability to trigger apoptosis and to contribute to the elimination of cancer cells by the immune system have been...
| Corporate Author: | SpringerLink (Online service) |
|---|---|
| Other Authors: | Micheau, Olivier (Editor) |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Cham :
Springer International Publishing : Imprint: Springer,
2017.
|
| Series: | Resistance to Targeted Anti-Cancer Therapeutics,
12 |
| Subjects: | |
| Online Access: | Full Text via HEAL-Link |
Similar Items
-
Death Receptors and Cognate Ligands in Cancer
Published: (2009) -
Immunotherapy of Cancer
Published: (2006) -
Bioinformatics in Cancer and Cancer Therapy
Published: (2009) -
Perspectives in Cancer Prevention-Translational Cancer Research
Published: (2014) -
STAT Inhibitors in Cancer
Published: (2016)